← All organizations

Origimm Biotechnology GmbH

For profit

Also known as: Origimm Biotechnology GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Sep 28, 2021

Acquired by Sanofi-Aventis on Dec 19, 2021

Timeline

2010s

Jun 1, 2012
Origimm Biotechnology GmbH— Founded

2020s

Dec 19, 2021
Sanofi-Aventis— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 1 (1 own, 0 via acquisition)

c. acnes vaccine

Recent trials (2)

NCT05131373Study directorPhase 1Sep 28, 2021
NCT05131373Lead sponsorPhase 1Sep 28, 2021

Details

Founded: Vienna, AT Jun 1, 2012
Last known activity: Sep 28, 2021